Revealing the Macromolecular Targets of Fragment-Like Natural Products.

Fragment-like natural products were identified as ligand-efficient chemical matter for hit-to-lead development and chemical-probe discovery. Relying on a computational method using a topological pharmacophore descriptor and a drug database, several macromolecular targets from distinct protein families were expeditiously retrieved for structurally unrelated chemotypes. The selected fragments feature structural dissimilarity to the reference compounds and suitable target affinity, and they offer opportunities for chemical optimization. Experimental confirmation of hitherto unknown macromolecular targets for the selected molecules corroborate the usefulness of the computational approach and suggests broad applicability to chemical biology and molecular medicine.

[1]  The synthesis of 1‐methyl‐5‐(α‐indolyl)imidazole and 1‐methyl‐2‐ethylthiol‐5‐(α‐indolyl)imidazole , 1968 .

[2]  T. Kohonen.  Self-organized formation of topographically correct feature maps , 1982 .

[3]  Jeremy Wright,et al.  Inhibition of dopamine β-hydroxylase by goitrin, a natural antithyroid compound , 1988 .

[4]  A. Zilberstein,et al.  A new series of PDGF receptor tyrosine kinase inhibitors: 3-substituted quinoline derivatives. , 1994, Journal of medicinal chemistry.

[5]  R. Glen,et al.  Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. , 1995, Journal of molecular biology.

[6]  P. Prasit,et al.  Synthesis and biological evaluation of 2,3-diarylthiophenes as selective Cox-2 and Cox-1 inhibitors , 1995 .

[7]  G. Schneider,et al.  Scaffold architecture and pharmacophoric properties of natural products and trade drugs: application in the design of natural product-based combinatorial libraries. , 2001, Journal of combinatorial chemistry.

[8]  Hsien-Chang Chang,et al.  Cytotoxic and antiplatelet aggregation principles of Ruta graveolens , 2003 .

[9]  M. Congreve,et al.  A 'rule of three' for fragment-based lead discovery? , 2003, Drug discovery today.

[10]  Gisbert Schneider,et al.  Collection of bioactive reference compounds for focused library design , 2003 .

[11]  Teuvo Kohonen,et al.  Self-organized formation of topologically correct feature maps , 2004, Biological Cybernetics.

[12]  Sophie A. L. Rousseaux,et al.  A solution to the 2-pyridyl organometallic cross-coupling problem: regioselective catalytic direct arylation of pyridine N-oxides. , 2005, Journal of the American Chemical Society.

[13]  A. Schuffenhauer,et al.  Charting biologically relevant chemical space: a structural classification of natural products (SCONP). , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Sorel Muresan,et al.  ChemGPS-NP: tuned for navigation in biologically relevant chemical space. , 2006, Journal of natural products.

[15]  B. Blumberg,et al.  The Dietary Isothiocyanate Sulforaphane Is an Antagonist of the Human Steroid and Xenobiotic Nuclear Receptor , 2007, Molecular Pharmacology.

[16]  Michael J. Keiser,et al.  Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.

[17]  Stefan Günther,et al.  SuperPred: drug classification and target prediction , 2008, Nucleic Acids Res..

[18]  Stefan Wetzel,et al.  Bioactivity-guided mapping and navigation of chemical space. , 2009, Nature chemical biology.

[19]  Judith M. Rollinger,et al.  Accessing target information by virtual parallel screening—The impact on natural product research , 2009 .

[20]  Stefan Wetzel,et al.  Interactive exploration of chemical space with Scaffold Hunter. , 2009, Nature chemical biology.

[21]  P Schneider,et al.  Self-organizing maps in drug discovery: compound library design, scaffold-hopping, repurposing. , 2009, Current medicinal chemistry.

[22]  C. Murray,et al.  The rise of fragment-based drug discovery. , 2009, Nature chemistry.

[23]  Thierry Langer,et al.  In silico Target Fishing for Rationalized Ligand Discovery Exemplified on Constituents of Ruta graveolens , 2008, Planta medica.

[24]  N. Kishore,et al.  Alkaloids as potential anti-tubercular agents. , 2009, Fitoterapia.

[25]  Michael J. Keiser,et al.  Predicting new molecular targets for known drugs , 2009, Nature.

[26]  B. Kuhn,et al.  A Medicinal Chemist’s Guide to Molecular Interactions , 2010, Journal of medicinal chemistry.

[27]  Vladimir Poroikov,et al.  Multi-targeted natural products evaluation based on biological activity prediction with PASS. , 2010, Current pharmaceutical design.

[28]  Zhishu Huang,et al.  Synthesis and evaluation of graveoline and graveolinine derivatives with potent anti-angiogenesis activities. , 2010, European journal of medicinal chemistry.

[29]  J. Baell,et al.  New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays. , 2010, Journal of medicinal chemistry.

[30]  Alexander Golbraikh,et al.  Development, validation, and use of quantitative structure-activity relationship models of 5-hydroxytryptamine (2B) receptor ligands to identify novel receptor binders and putative valvulopathic compounds among common drugs. , 2010, Journal of medicinal chemistry.

[31]  N. Walker,et al.  A novel series of IKKβ inhibitors part I: Initial SAR studies of a HTS hit. , 2011, Bioorganic & medicinal chemistry letters.

[32]  Justin D Dietrich,et al.  Synthesis and biological activity of 2-aminothiazoles as novel inhibitors of PGE2 production in cells. , 2012, Bioorganic & medicinal chemistry letters.

[33]  Stefan Wetzel,et al.  Natural-product-derived fragments for fragment-based ligand discovery , 2012, Nature Chemistry.

[34]  Maria F. Sassano,et al.  Automated design of ligands to polypharmacological profiles , 2012, Nature.

[35]  Jordi Mestres,et al.  Identification of pim kinases as novel targets for PJ34 with confounding effects in PARP biology. , 2012, ACS chemical biology.

[36]  Michael J. Keiser,et al.  Large Scale Prediction and Testing of Drug Activity on Side-Effect Targets , 2012, Nature.

[37]  Petra Schneider,et al.  Chemically Advanced Template Search (CATS) for Scaffold-Hopping and Prospective Target Prediction for ‘Orphan’ Molecules , 2013, Molecular informatics.

[38]  H. Waldmann,et al.  Catalytic enantioselective synthesis of functionalized tropanes reveals novel inhibitors of hedgehog signaling. , 2013, Angewandte Chemie.

[39]  Martin Augustin,et al.  A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery. , 2013, The Biochemical journal.

[40]  Petra Schneider,et al.  Revealing the macromolecular targets of complex natural products. , 2014, Nature chemistry.

[41]  Petra Schneider,et al.  Identifying the macromolecular targets of de novo-designed chemical entities through self-organizing map consensus , 2014, Proceedings of the National Academy of Sciences.

[42]  Lin Du,et al.  Crowdsourcing natural products discovery to access uncharted dimensions of fungal metabolite diversity. , 2014, Angewandte Chemie.

[43]  J. Aubé,et al.  Probing Chemical Space with Alkaloid-Inspired Libraries , 2014, Nature chemistry.

[44]  J. E. Robinson,et al.  Discovery of a Novel Class of Imidazo[1,2-a]Pyridines with Potent PDGFR Activity and Oral Bioavailability. , 2014, ACS medicinal chemistry letters.

[45]  Petra Schneider,et al.  Multi-objective molecular de novo design by adaptive fragment prioritization. , 2014, Angewandte Chemie.

[46]  George Papadatos,et al.  The ChEMBL bioactivity database: an update , 2013, Nucleic Acids Res..

[47]  Herbert Waldmann,et al.  Biology-oriented synthesis: harnessing the power of evolution. , 2014, Journal of the American Chemical Society.

[48]  H. Waldmann,et al.  An enantioselective inverse-electron-demand imino Diels-Alder reaction. , 2014, Angewandte Chemie.

[49]  Petra Schneider,et al.  Mehrdimensionales De‐novo‐Moleküldesign durch adaptive Fragmentauswahl , 2014 .

[50]  A. Bauer,et al.  Industrial natural product chemistry for drug discovery and development. , 2014, Natural product reports.

[51]  Petra Schneider,et al.  Chemography of Natural Product Space , 2015, Planta Medica.

[52]  J Willem M Nissink,et al.  Promiscuous 2-aminothiazoles (PrATs): a frequent hitting scaffold. , 2015, Journal of medicinal chemistry.

[53]  G. Schneider,et al.  Repurposing de novo designed entities reveals phosphodiesterase 3B and cathepsin L modulators. , 2015, Chemical communications.

[54]  A. Harvey,et al.  The re-emergence of natural products for drug discovery in the genomics era , 2015, Nature Reviews Drug Discovery.

[55]  Jordi Mestres,et al.  Distant polypharmacology among MLP chemical probes. , 2015, ACS chemical biology.

[56]  M. Malkowski,et al.  The structure of ibuprofen bound to cyclooxygenase-2. , 2014, Journal of structural biology.

[57]  Gisbert Schneider,et al.  Multidimensional de novo design reveals 5-HT2B receptor-selective ligands. , 2015, Angewandte Chemie.